Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 26.08.2022.

#BioSpace
#PharmaJobs
#JobOpportunities
#Pharmaceuticals
#LifeScienceIndustry
#EconomicGrowth
#NBTintheNews

@biospace shared
On Aug 23, 2022
The pharmaceutical industry is full of job opportunities for people in various fields. Read on to find out more information about high-paying pharma industry jobs. #Pharmaceuticals #PharmaJobs #JobOpportunities #BioSpace https://t.co/0Tcln4dk1C
Open
8 High-Paying Pharma Industry Jobs

8 High-Paying Pharma Industry Jobs

The pharmaceutical industry is full of job opportunities for people in various fields. Read on to find out more information about high-paying pharma industry jobs.

@JohnCendpts shared
On Aug 19, 2022
Yeah...about that. https://t.co/Bw6LY7bVR7
Open
Fewer than 40% of new accelerated approvals demonstrate 'high' therapeutic value, study says

Fewer than 40% of new accelerated approvals demonstrate 'high' therapeutic value, study says

As Congress continues to mull whether and how to reform the FDA's accelerated approval pathway, new research on the pathway continues to crop up, attempting to guide the way for new ...

@MALifeSciences shared
On Aug 24, 2022
Kudos to our partners at @thermofisher on the expansion of its cell and gene therapy capabilities with the opening of its new viral vector manufacturing facility in Plainville, Mass. ✂️🎀 🔗 https://t.co/jhIdzWJJpr https://t.co/ortDO9s4Ia
Open
Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

N ew state-of-the-art facility in Plainville, Mass., to manufacture materials central to production of gene-based therapeutics Thermo Fisher Scientific, the world leader in serving science, ...

@WSJhealth shared
On Aug 26, 2022
RT @jonathanrockoff: The patent litigation filed by Moderna against its mRNA rivals augurs what will likely be a years-long confrontation, and might also mark the end of a period of unusual comity among big drugmakers, @joewalkerWSJ reports. https://t.co/oXAZJwS4l5
Open
Moderna Sues Pfizer and BioNTech, Alleging Infringement of MRNA Patents

Moderna Sues Pfizer and BioNTech, Alleging Infringement of MRNA Patents

Moderna said its rivals copied its methods for encoding genetic material and used the same chemical modification in their Covid-19 vaccine.

@MassBioEd shared
On Aug 25, 2022
We are proud and grateful to be a partner of the @biogen Foundation and are excited to celebrate its 20th anniversary this year! Read about the impact Biogen's partnership has had on our BioTeach program and the teaching community: https://t.co/aQCOn2aE9L https://t.co/lYT6ySHrTZ
Open
Biogen Foundation Celebrates Grantee MassBioEd’s Impact for 20th Anniversary

Biogen Foundation Celebrates Grantee MassBioEd’s Impact for 20th Anniversary

Biogen is celebrating the 20th anniversary of the Biogen Foundation and Biogen Community Lab this year, recognizing 20 years of caring deeply in the communities we serve. Established in ...

@biospace shared
On Aug 23, 2022
Throughout the United States and globally, clusters of innovation have created self-sustaining ecosystems that are shaping the future of the life sciences industry - and driving economic growth. #LifeScienceIndustry #EconomicGrowth #BioSpace https://t.co/U6VABqsPdm
Open
Innovation Hubs are Driving Economic Growth Across the US

Innovation Hubs are Driving Economic Growth Across the US

Across the United States, Clusters of innovation have created self-sustaining ecosystems that are shaping the future of the life sciences industry - and driving economic growth.

@SynBioBeta shared
On Aug 25, 2022
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. https://t.co/PLS83tmoKh
Open
A cellular engineering breakthrough: High-yield CRISPR without viral vectors

A cellular engineering breakthrough: High-yield CRISPR without viral vectors

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone ...

@NatureBiotech shared
On Aug 24, 2022
Corneas made from pig collagen return sight to 20 people #NBTintheNews via @elpaisinenglish https://t.co/lYP9TiENHU
Open
Corneas made from pig collagen return sight to 20 people

Corneas made from pig collagen return sight to 20 people

A pilot study with bioengineered corneal tissue is paving the way for an alternative to human transplants